Breast Cancer ED
- Detection of early gastric cancer & precancerous lesions
0
People watching this product now!
- Sensitivity 80.71%
- Specificity 92.79%
- A blood-based test for diagnosis of breast cancer by detecting a combination of proprietary epigenomics DNA methylation biomarkers.
- Detection of early gastric cancer & precancerous lesions.
- Patients with a positive test result should be referred for diagnostic mammography or ultrasound.
- Patients with a negative test result should discuss with their doctor when they need to be tested again.
- Follow-up & monitoring
- Prognostic evaluation
- Therapeutic assessment
- Male & female aged 40 and above.
- A history of breast or ovarian cancer, the risk is higher when two or more family members have had breast or ovarian cancer. It is also higher if one or more family members have breast or ovarian cancer aged less than 40.
- Breast cancer genetic background, like BRAC1/2 mutation.
- A history of benign breast disease(s), like atypical ductal and lobular hyperplasia.
- Women with early menarche (before 12 years old) or late menopause (after 55 years old).
